NARI vs. ICUI, TNDM, IART, ATEC, PRCT, LMAT, IRTC, NVCR, AXNX, and MDXG
Should you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Integra LifeSciences (IART), Alphatec (ATEC), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), iRhythm Technologies (IRTC), NovoCure (NVCR), Axonics (AXNX), and MiMedx Group (MDXG). These companies are all part of the "surgical & medical instruments" industry.
Inari Medical (NASDAQ:NARI) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends, valuation and community ranking.
91.0% of Inari Medical shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 10.6% of Inari Medical shares are owned by insiders. Comparatively, 6.7% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
ICU Medical received 325 more outperform votes than Inari Medical when rated by MarketBeat users. However, 68.24% of users gave Inari Medical an outperform vote while only 64.48% of users gave ICU Medical an outperform vote.
Inari Medical has higher earnings, but lower revenue than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
ICU Medical has a net margin of -2.63% compared to Inari Medical's net margin of -4.54%. ICU Medical's return on equity of 5.38% beat Inari Medical's return on equity.
In the previous week, ICU Medical had 1 more articles in the media than Inari Medical. MarketBeat recorded 11 mentions for ICU Medical and 10 mentions for Inari Medical. ICU Medical's average media sentiment score of 0.62 beat Inari Medical's score of 0.49 indicating that ICU Medical is being referred to more favorably in the news media.
Inari Medical currently has a consensus price target of $65.71, indicating a potential upside of 44.43%. ICU Medical has a consensus price target of $123.00, indicating a potential upside of 16.86%. Given Inari Medical's higher probable upside, analysts clearly believe Inari Medical is more favorable than ICU Medical.
Inari Medical has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.
Summary
ICU Medical beats Inari Medical on 10 of the 18 factors compared between the two stocks.
Get Inari Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NARI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inari Medical Competitors List
Related Companies and Tools
